Sign up to save your podcasts
Or
Share The State of AI in 2023: Navigating Growth, Regulation, and Responsible Practices
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The State of AI in 2023: Navigating Growth, Regulation, and Responsible Practices
The current state of the AI industry is marked by significant momentum and growth, despite some recent market fluctuations. According to Vellum's 2025 State of AI Development Report, 25% of developers have production AI applications, and 39% are in various testing phases[1]. This indicates a substantial increase in enterprise AI adoption, with organizations moving beyond the hype to create practical, value-driving applications.
OpenAI continues to lead in AI development, with GPT-4o being the most popular model among developers, used by 64.9% of respondents[1]. The Microsoft-OpenAI partnership has also emerged as a frontrunner, democratizing access to advanced AI capabilities and enabling organizations of all sizes to build sophisticated applications.
In terms of market movements, the AI industry saw a decline in private investment in 2022, with global AI private investment decreasing by 26.7% to $91.9 billion[2]. However, the 2024 AI Index Report notes that generative AI investment surged, nearly octupling from 2022 to reach $25.2 billion[4].
Emerging competitors are also making their mark, with industrial AI agents becoming increasingly popular. These agents utilize algorithms and data models specifically optimized for particular domains, offering more accurate and relevant guidance[3]. Companies like Aker BP are already demonstrating the transformative power of domain-specific AI agents, streamlining equipment management processes and saving thousands of hours.
Regulatory changes are also on the horizon, with a shift towards self-governance expected to create more space for innovation[5]. Pharmaceutical and medtech companies are expected to be at the forefront of using AI to revolutionize their value chains, especially for drug and product development.
In terms of consumer behavior, there is a growing confidence in AI reliability and effectiveness, with 55% of developers planning to build complex agentic workflows in 2025[1]. However, there is still a need for better expertise and tooling to continue driving adoption.
Compared to previous reporting, the AI industry has made significant progress in terms of adoption and investment. However, there is still a need for more systematic and transparent approaches to confirming sustained value from AI investments, as well as managing the risks of large-scale deployment[5].
Overall, the AI industry is poised for continued growth and innovation, with emerging competitors, new product launches, and regulatory changes shaping the landscape. As AI becomes increasingly intrinsic to operations and market offerings, companies will need to prioritize responsible AI practices and rigorous assessment and validation of AI risk management practices.
OpenAI continues to lead in AI development, with GPT-4o being the most popular model among developers, used by 64.9% of respondents[1]. The Microsoft-OpenAI partnership has also emerged as a frontrunner, democratizing access to advanced AI capabilities and enabling organizations of all sizes to build sophisticated applications.
In terms of market movements, the AI industry saw a decline in private investment in 2022, with global AI private investment decreasing by 26.7% to $91.9 billion[2]. However, the 2024 AI Index Report notes that generative AI investment surged, nearly octupling from 2022 to reach $25.2 billion[4].
Emerging competitors are also making their mark, with industrial AI agents becoming increasingly popular. These agents utilize algorithms and data models specifically optimized for particular domains, offering more accurate and relevant guidance[3]. Companies like Aker BP are already demonstrating the transformative power of domain-specific AI agents, streamlining equipment management processes and saving thousands of hours.
Regulatory changes are also on the horizon, with a shift towards self-governance expected to create more space for innovation[5]. Pharmaceutical and medtech companies are expected to be at the forefront of using AI to revolutionize their value chains, especially for drug and product development.
In terms of consumer behavior, there is a growing confidence in AI reliability and effectiveness, with 55% of developers planning to build complex agentic workflows in 2025[1]. However, there is still a need for better expertise and tooling to continue driving adoption.
Compared to previous reporting, the AI industry has made significant progress in terms of adoption and investment. However, there is still a need for more systematic and transparent approaches to confirming sustained value from AI investments, as well as managing the risks of large-scale deployment[5].
Overall, the AI industry is poised for continued growth and innovation, with emerging competitors, new product launches, and regulatory changes shaping the landscape. As AI becomes increasingly intrinsic to operations and market offerings, companies will need to prioritize responsible AI practices and rigorous assessment and validation of AI risk management practices.
View all episodes
By Quiet. PleaseThe current state of the AI industry is marked by significant momentum and growth, despite some recent market fluctuations. According to Vellum's 2025 State of AI Development Report, 25% of developers have production AI applications, and 39% are in various testing phases[1]. This indicates a substantial increase in enterprise AI adoption, with organizations moving beyond the hype to create practical, value-driving applications.
OpenAI continues to lead in AI development, with GPT-4o being the most popular model among developers, used by 64.9% of respondents[1]. The Microsoft-OpenAI partnership has also emerged as a frontrunner, democratizing access to advanced AI capabilities and enabling organizations of all sizes to build sophisticated applications.
In terms of market movements, the AI industry saw a decline in private investment in 2022, with global AI private investment decreasing by 26.7% to $91.9 billion[2]. However, the 2024 AI Index Report notes that generative AI investment surged, nearly octupling from 2022 to reach $25.2 billion[4].
Emerging competitors are also making their mark, with industrial AI agents becoming increasingly popular. These agents utilize algorithms and data models specifically optimized for particular domains, offering more accurate and relevant guidance[3]. Companies like Aker BP are already demonstrating the transformative power of domain-specific AI agents, streamlining equipment management processes and saving thousands of hours.
Regulatory changes are also on the horizon, with a shift towards self-governance expected to create more space for innovation[5]. Pharmaceutical and medtech companies are expected to be at the forefront of using AI to revolutionize their value chains, especially for drug and product development.
In terms of consumer behavior, there is a growing confidence in AI reliability and effectiveness, with 55% of developers planning to build complex agentic workflows in 2025[1]. However, there is still a need for better expertise and tooling to continue driving adoption.
Compared to previous reporting, the AI industry has made significant progress in terms of adoption and investment. However, there is still a need for more systematic and transparent approaches to confirming sustained value from AI investments, as well as managing the risks of large-scale deployment[5].
Overall, the AI industry is poised for continued growth and innovation, with emerging competitors, new product launches, and regulatory changes shaping the landscape. As AI becomes increasingly intrinsic to operations and market offerings, companies will need to prioritize responsible AI practices and rigorous assessment and validation of AI risk management practices.
OpenAI continues to lead in AI development, with GPT-4o being the most popular model among developers, used by 64.9% of respondents[1]. The Microsoft-OpenAI partnership has also emerged as a frontrunner, democratizing access to advanced AI capabilities and enabling organizations of all sizes to build sophisticated applications.
In terms of market movements, the AI industry saw a decline in private investment in 2022, with global AI private investment decreasing by 26.7% to $91.9 billion[2]. However, the 2024 AI Index Report notes that generative AI investment surged, nearly octupling from 2022 to reach $25.2 billion[4].
Emerging competitors are also making their mark, with industrial AI agents becoming increasingly popular. These agents utilize algorithms and data models specifically optimized for particular domains, offering more accurate and relevant guidance[3]. Companies like Aker BP are already demonstrating the transformative power of domain-specific AI agents, streamlining equipment management processes and saving thousands of hours.
Regulatory changes are also on the horizon, with a shift towards self-governance expected to create more space for innovation[5]. Pharmaceutical and medtech companies are expected to be at the forefront of using AI to revolutionize their value chains, especially for drug and product development.
In terms of consumer behavior, there is a growing confidence in AI reliability and effectiveness, with 55% of developers planning to build complex agentic workflows in 2025[1]. However, there is still a need for better expertise and tooling to continue driving adoption.
Compared to previous reporting, the AI industry has made significant progress in terms of adoption and investment. However, there is still a need for more systematic and transparent approaches to confirming sustained value from AI investments, as well as managing the risks of large-scale deployment[5].
Overall, the AI industry is poised for continued growth and innovation, with emerging competitors, new product launches, and regulatory changes shaping the landscape. As AI becomes increasingly intrinsic to operations and market offerings, companies will need to prioritize responsible AI practices and rigorous assessment and validation of AI risk management practices.